XML 52 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value of Financial Instruments (Tables)
3 Months Ended
Apr. 02, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Hierarchy
At April 2, 2023, March 27, 2022 and December 25, 2022, the Company had the following assets and liabilities measured at fair value in its consolidated balance sheets (excluding assets for which the fair value is measured using net asset value per share):
Fair Value Measurements Using:
Fair
Value
Quoted
Prices in
Active
Markets
for
Identical
Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
April 2, 2023
Assets:
Available-for-sale securities$1.3 1.3 — — 
Derivatives3.2 — 3.2 — 
Total assets$4.5 1.3 3.2 — 
Liabilities:
Derivatives$5.2 — 5.2 — 
Option agreement1.7 — — 1.7 
Total liabilities$6.9 — 5.2 1.7 
March 27, 2022
Assets:
Available-for-sale securities$1.6 1.6 — — 
Derivatives9.9 — 9.9 — 
Total assets$11.5 1.6 9.9 — 
Liabilities:
Derivatives$4.6 — 4.6 — 
Option agreement1.7 — — 1.7 
Total liabilities$6.3 — 4.6 1.7 
December 25, 2022
Assets:
Available-for-sale securities$1.7 1.7 — — 
Derivatives7.9 — 7.9 — 
Total assets$9.6 1.7 7.9 — 
Liabilities:
Derivatives$2.9 — 2.9 — 
Option agreement1.7 — — 1.7 
Total Liabilities$4.6 — 2.9 1.7 
Schedule of Reconciliation of Level 3 Fair Value
The following is a reconciliation of the beginning and ending balances of the fair value measurements of the Company's financial instruments which use significant unobservable inputs (Level 3):
20232022
Balance at beginning of year$(1.7)$(1.7)
Balance at end of first quarter$(1.7)$(1.7)